[HTML][HTML] Prescribing patterns of statins and associated factors among type 2 diabetes mellitus patients in Africa: a systematic review and meta-analysis

WC Tassew, YA Ferede, AM Zeleke - Metabolism Open, 2024 - Elsevier
Abstract Background In sub-Saharan African nations, there's a documented shortfall in the
utilization of statins, despite established clinical guidelines advocating their use for reducing …

Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study …

EE Melaku, ET Ayele, BM Urgie… - Vascular Health and …, 2023 - Taylor & Francis
Background Atherosclerosis-related cardiovascular diseases (coronary heart diseases,
ischemic stroke, and peripheral vascular diseases) account for the majority of deaths in …

Adherence to clinical guidelines on STATIN prescribing among diabetic patients aged 40–75 years old in a primary care setting: a cross-sectional study

AD Abukhalil, M Alyan, W AbuAita… - Patient preference …, 2022 - Taylor & Francis
Background Diabetes mellitus (DM) is a chronic metabolic disease caused by decreased
insulin secretion, which increases the risk of cardiovascular diseases. Evidence has shown …

Statin Prescription Patterns Among Elderly Patients with Type 2 Diabetes: A Cross-Sectional Study in Lebanon

F Al Souheil, B Chahine - Drugs-Real World Outcomes, 2023 - Springer
Background Even though statins have been proven to be effective in both primary and
secondary prevention of cardiovascular disease among diabetic patients, a suboptimal use …

Prescribing patterns of statins and associated factors among type 2 diabetes mellitus patients attended at Jugol General Hospital in eastern Ethiopia: A cross-sectional …

S Nigussie, F Demeke - Frontiers in clinical diabetes and healthcare, 2023 - frontiersin.org
Background Most clinical practice guidelines support the use of statins in patients with type 2
diabetes mellitus to lower the risk of cardiovascular disease. However, nothing is known …

[PDF][PDF] Use of Antiplatelet and Lipid Lowering Agent Therapies as Primary Cardiovascular Disease Prevention Strategy and their Determinant Factors among Type 2 …

T Solomon, S Tadesse, A Tewabe, T Tsehay - Diabetes Case Rep, 2023 - researchgate.net
Background: Patients with type 2 diabetes mellitus have two to four times increased risk of
cardiovascular events compared with those without diabetes. Anti-platelet therapy and lipid …

[引用][C] Adherence to Clinical Guidelines on STATIN Prescribing Among Diabetic Patients Aged 40–75 Years Old in ampere Primary Service Setting: A Cross-Sectional …

A ADVERTISE, M Alyan, W AbuAita, N Al-Shami…